EPISODE · Jan 22, 2023 · 35 MIN
#104: Revolutionizing Respiratory Antivirals: The Science behind G.ST Antivirals
from Beginner's Mind · host Christian Soschner
On this episode of "Year in Review Recording," we speak with Guido Gualdoni, Co-Founder, and CEO of G.ST Antivirals, a clinical-stage biotech company revolutionizing how we treat viral infections of the respiratory tract. Guido shares the science behind G.ST Antivirals' innovative host cell-based strategy to develop broad-spectrum antivirals and how it completely eliminates viral reproduction without the risk of resistance development. He also delves into the public funding and startup ecosystem in Vienna, Austria, which has been instrumental in the company's success. He also talks about the future plans for G.ST Antivirals and the deep scientific tech valley in Central Europe. This episode is a must-listen for anyone interested in the latest advancements in biotech and the companies leading the way in treating viral infections. 💡 LINKS TO MORE CONTENT.If you like the episode, become a subscriber and support the show: https://lsg2g.substack.com/subscribePodcast Episodes: https://pod.link/1493847125Please support this show by checking out the companies that make it possible: https://linktr.ee/lsg2Watch on YoutubeGuido GualdoniChristian Soschner⏰ Timestamps:(00:00) Welcome to the Episode: Exploring the Public Funding and Eco-System in Vienna, Austria(02:35) Meet Guido Gualdoni, CEO of G.ST Antiviral(04:00) Discovering the StartUp Labs, Vienna Business Agency, AWS, FFG, Austrian Business Agency, LISA Vienna and their role in supporting startups(07:35) Exploring the Scientific Deep Tech Valley in Central Europe: Munich, Vienna, Zurich, Prague(10:15) G.ST Antiviral's 2022 Outlook(11:22) Uncovering the Innovative Technology Behind G.ST Antiviral(14:30) Guido's Biggest Takeaways from 2022(16:15) Why Optimism Bias Can be a Challenge for Entrepreneurs(18:15) Comparing the Scientific and Entrepreneurial Mindsets(24:00) The Surprising Companies that Succeeded During Economic Downturns(25:00) Examining the Latest Trends in Antiinfectious Diseases(27:45) Charting the Growth of G.ST Antiviral in 2023Send us Fan Mail Join Christian Soschner for expert coaching. 50% Off - With 35+ years in deep tech, startups/scaleups, and public companies, Christian offers power video sessions. Elevate strategy, execution, and leadership. Book Now.Support the showJoin the Podcast Newsletter: Link
Embed this episode
What this episode covers
On this episode of "Year in Review Recording," we speak with Guido Gualdoni, Co-Founder, and CEO of G.ST Antivirals, a clinical-stage biotech company revolutionizing how we treat viral infections of the respiratory tract. Guido shares the science behind G.ST Antivirals' innovative host cell-based strategy to develop broad-spectrum antivirals and how it completely eliminates viral reproduction without the risk of resistance development. He also delves into the public funding and startup...
NOW PLAYING
#104: Revolutionizing Respiratory Antivirals: The Science behind G.ST Antivirals
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.